Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. (PYXS)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
2. 36
+0.13
+5.8296%
$
145.08M Market Cap
- P/E Ratio
- Div Yield
380,400 Volume
-0.91 Eps
$ 2.23
Previous Close
Analysts:
Add Transaction
Day Range
2.18 2.39
Year Range
0.97 5.55
Want to track PYXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Pyxis Oncology, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
32,006 $36,806.83 $75,534.16 $38,727.33 105.22%
Kyle P. Smith
Kyle P. Smith NewEdge Wealth LLC
116,006 $425,735.69 $273,774.16 -$151,961.53 -35.69%
RF
Rekah Franca Catalyst Funds Management Pty Ltd.
20,400 $29,784 $48,858 $19,074 64.04%
Li Peng
Li Peng China Universal Asset Management Co. Ltd.
11,049 $16,909.7 $27,014.8 $10,105.1 59.76%
HFT
Hui Fai Tam Caitong International Asset Management Co. Ltd.
4 $6 $9.19 $3.19 53.17%
Chandler te Velde
Chandler te Velde Maia Wealth LLC
21,277 $24,468.55 $48,086.02 $23,617.47 96.52%
Hager Investment Management Services LLC
Hager Investment Management Services LLC HAGER INVESTMENT MANAGEMENT SERVICES, LLC
5,000 $7,300 $11,175 $3,875 53.08%
Scott Schroeder
Scott Schroeder Longaeva Partners LP
503,214 $1.12M $1.14M $22,644.73 2.03%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
1,316 $1,944.21 $2,940.87 $996.66 51.26%